招银国际_Stronger into 2026 on 1.6T ramp and SiPh mix_20260401.pdf
摘要
文本

Innolight (300308 CH)
Innolight delivered strong FY25 earnings, with revenue up 60% YoY to RMB38.2bn, in line with our estimate and Bloomberg consensus, while net profit rose 109% YoY to RMB10.8bn, 1.4% below our forecast but broadly in line with consensus. GPM improved sharply to 42.6% from 34.7% in FY24, driven by continued strength in high-speed optical module shipments and higher SiPh mix. Momentum accelerated further in 4Q25, with revenue up 102% YoY and 30% QoQ, while GPM expanded to 44.5% from 42.8% in 3Q25. We continue to view Innolight as a key domestic AI beneficiary, supported by improving supplychain readiness, clear leadership in pluggable modules, and further margin upside from deeper SiPh penetration. Maintain BUY, with TP unchanged at RMB707, based on 28x 2026E P/E.
Capacity expanded by 34% YoY in FY25, while shipments grew 45% highlighting robust demand and solid ramp execution. Utilization improved from 74% in FY24 to 85% in FY25, while overseas sales accounted for 92% of revenue and 86% of total shipments. Looking ahead in FY26E, we expect 800G to remain the primary shipment driver, while 1.6T should increasingly emerge as the key revenue and GPM growth driver, supported by higher SiPh penetration and a more favorable mix. Mgmt. also indicated it has strengthened supply assurance for key materials through tighter agreements with core suppliers, higher strategic inventory, and broader vendor qualification, which we believe should improve delivery visibility and support growth into FY26-27.
Looking beyond the current ramp, we believe the Company's product roadmap remains one of the strongest in the sector. Mgmt. sees 800G and 1.6T as the core demand pillars in FY26, with 1.6T likely to scale much faster as adoption broadens across CSPs and AI infrastructure customers. At the same time, the Company is positioning for the next phase of optical interconnect demand across scale-up and scale-cross networks, while continuing to advance its 3.2T roadmap across multiple technology paths, including EML-based and SiPh-based solutions. We expect 3.2T pluggable modules to begin to contribute revenue in FY28E.
Earnings Summary
(YE 31 Dec)
FY24A
FY25A
FY26E
FY27E
FY28E
Revenue (RMB mn)
23,862
38,240
84,065
121,495
175,287
YoY growth(%)
122.6
60.3
119.8
44.5
44.3
Gross margin(%)
33.8
42.0
45.6
46.6
48.5
Net profit (RMB mn)
5,171.5
10,797.3
28,040.8
42,888.3
66,064.9
YoY growth(%)
137.9
108.8
159.7
52.9
54.0
EPS(Reported)(RMB)
4.72
9.80
25.24
38.60
59.46
P/E(x)
120.6
58.1
22.6
14.8
9.6
Stronger into 2026 on 1.6T ramp and SiPh mix
Source: Company data, Bloomberg, CMBIGM estimates
Maintain BUY, with TP unchanged at RMB707, based on the same 28x 2026E P/E. We remain positive on the Company's earnings outlook, driven by sustained 800G volume growth, rising 1.6T contribution, and further margin upside from deeper SiPh penetration. We lift our FY27E sales/net profit forecast by 8%/12% as the Company continues to scale capacity to meet robust demand on top of enhancing cost controls.
BUY (Maintain)
Target Price RMB707.00
Up/Downside 24.2%
Current Price RMB569.41
China Semiconductors
Kevin ZHANG
(852) 37618727
kevinzhang@cmbi.com.hk
Aaron GUO
(852) 39163715
aaronguo@cmbi.com.hk
Stock Data
Mkt Cap (RMB mn)
632,671.5
Avg 3 mths t/o (RMB mn)
18,840.1
52w High/Low (RMB)
649.00/71.99
Total Issued Shares (mn)
1111.1
Source: FactSet
Shareholding Structure
Shandong Zhongji Investment Holdings Co.
10.9%
Wang Weixiu
6.3%
Source: Bloomberg
Share Performance
Absolute
Relative
1-mth
6.6%
16.2%
3-mth
-6.7%
-6.8%
6-mth
41.1%
40.2%
Source: FactSet
12-mth Price Performance

Source: FactSet

Figure 1: Earnings revision
New
Old
Diff(%)
RMBmn
FY26E
FY27E
FY28E
FY26E
FY27E
FY28E
FY26E
FY27E
FY28E
Revenue
84,065
121,495
175,287
83,794
112,154
NA
0.3%
8.3%
NA
Gross profit
38,301
56,591
85,071
38,713
51,927
NA
-1.1%
9.0%
NA
Net profit
28,041
42,888
66,065
27,774
38,357
NA
1.0%
11.8%
NA
EPS(RMB)
25.24
38.60
59.46
25.23
34.85
NA
0.0%
10.8%
NA
Gross margin
45.6%
46.6%
48.5%
46.2%
46.3%
NA
-0.6ppt
0.3ppt
NA
Net margin
33.4%
35.3%
37.7%
33.1%
34.2%
NA
0.2ppt
1.1ppt
NA
Source: Company data, CMBIGM estimates
Figure 2: CMBIGM estimates vs. BBG consensus
CMBIGM
BBG Consensus
Diff(%)
RMBmn
FY26E
FY27E
FY28E
FY26E
FY27E
FY28E
FY26E
FY27E
FY28E
Revenue
84,065
121,495
175,287
84,483
112,899
122,906
-0.5%
7.6%
42.6%
Gross profit
38,301
56,591
85,071
36,295
49,556
58,390
5.5%
14.2%
45.7%
Net profit
28,041
42,888
66,065
23,606
32,894
44,520
18.8%
30.4%
48.4%
EPS(RMB)
25.24
38.60
59.46
20.04
26.85
45.84
25.9%
43.8%
29.7%
Gross margin
45.6%
46.6%
48.5%
43.0%
43.9%
47.5%
2.6ppt
2.7ppt
1ppt
Net margin
33.4%
35.3%
37.7%
27.9%
29.1%
36.2%
5.4ppt
6.2ppt
1.5ppt
Source: Bloomberg consensus, CMBIGM estimates
Figure 3: Innolight's product mix forecast

Source: Company data, CMBIGM estimates
Figure 4: Innolight's GPM forecast

Figure 5: Forward P/E chart
Source: Company data, CMBIGM estimates

Source: Company data, CMBIGM estimates
Figure 6: P/E band

Source: Company data, CMBIGM estimates

Financial Summary
INCOME STATEMENT
2023A
2024A
2025A
2026E
2027E
2028E
YE 31 Dec (RMB mn)
Revenue
10,718
23,862
38,240
84,065
121,495
175,287
Cost of goods sold
(7,182)
(15,796)
(22,166)
(45,764)
(64,904)
(90,216)
Gross profit
3,536
8,067
16,074
38,301
56,591
85,071
Operating expenses
(1,042)
(2,017)
(2,477)
(4,966)
(5,875)
(6,946)
Selling expense
(51)
(47)
(78)
(171)
(182)
(263)
SG&A expense
(558)
(879)
(987)
(2,088)
(3,025)
(4,364)
R&D expense
(739)
(1,244)
(1,615)
(3,425)
(4,707)
(6,440)
Others
306
153
202
717
2,039
4,121
Operating profit
2,494
6,050
13,597
33,334
50,717
78,125
Other income
2
5
10
22
31
45
Other expense
(4)
(2)
(7)
(16)
(23)
(33)
Pre-tax profit
2,492
6,052
13,600
33,340
50,725
78,137
Income tax
(285)
(681)
(2,020)
(3,667)
(5,580)
(8,595)
After tax profit
2,208
5,372
11,580
29,673
45,146
69,542
Minority interest
34
200
782
1,632
2,257
3,477
Net profit
2,174
5,171
10,797
28,041
42,888
66,065
BALANCE SHEET
2023A
2024A
2025A
2026E
2027E
2028E
YE 31 Dec (RMB mn)
Current assets
11,319
18,196
31,084
57,579
104,507
165,819
Cash & equivalents
3,317
5,054
10,987
23,545
65,480
112,701
Account receivables
2,581
4,604
6,277
14,912
15,046
21,452
Inventories
4,295
7,051
12,681
17,411
21,710
27,724
Prepayment
59
80
134
236
341
491
Other current assets
1,067
1,407
1,005
1,475
1,931
3,451
Non-current assets
8,687
10,671
14,205
18,574
25,778
35,557
PP&E
3,948
5,820
7,081
11,257
14,553
19,829
Right-of-use assets
27
34
105
853
1,773
2,975
Deferred income tax
82
222
541
541
909
1,555
Intangibles
401
378
378
254
250
352
Goodwill
1,939
1,939
1,939
1,939
1,939
1,939
Other non-current assets
2,291
2,279
4,163
3,731
6,354
8,908
Total assets
20,007
28,866
45,289
76,153
130,285
201,377
Current liabilities
4,360
6,497
11,558
14,435
25,812
31,538
Short-term borrowings
62
1,426
301
913
1,491
1,807
Account payables
1,857
2,991
7,330
7,716
15,401
16,731
Tax payable
213
244
1,250
2,102
3,596
5,558
Other current liabilities
2,039
1,545
2,287
3,052
4,220
5,741
Contract liabilities
3
10
26
40
58
83
Accrued expenses
187
282
364
612
1,047
1,618
Non-current liabilities
872
2,076
2,109
3,199
5,111
7,621
Long-term borrowings
319
606
510
510
510
510
Bond payables
0
0
0
0
0
0
Deferred income
216
270
291
490
838
1,295
Other non-current liabilities
337
1,200
1,308
2,200
3,763
5,816
Total liabilities
5,232
8,573
13,668
17,634
30,922
39,160
Share capital
803
1,121
1,111
1,111
1,111
1,111
Retained earnings
5,870
10,624
20,248
45,065
82,962
141,280
Other reserves
7,589
7,388
8,406
8,856
9,544
10,604
Total shareholders equity
14,261
19,134
29,765
55,032
93,617
152,995
Minority interest
513
1,159
1,856
3,488
5,745
9,222
Total equity and liabilities
20,007
28,866
45,289
76,153
130,285
201,377

CASH FLOW
2023A
2024A
2025A
2026E
2027E
2028E
YE 31 Dec (RMB mn)
Operating
Profit before taxation
2,492
6,052
13,600
33,340
50,725
78,137
Depreciation & amortization
525
713
934
1,152
1,468
1,936
Tax paid
(285)
(681)
(2,020)
(3,667)
(5,580)
(8,595)
Change in working capital
(830)
(3,210)
(1,958)
(12,341)
4,520
(10,261)
Others
(6)
290
340
1,137
1,822
1,981
Net cash from operations
1,897
3,165
10,896
19,621
52,955
63,198
Investing
Capital expenditure
(1,704)
(2,866)
(2,760)
(4,899)
(7,079)
(10,213)
Acquisition of subsidiaries/ investments
(3,971)
(2,725)
0
0
0
0
Net proceeds from disposal of short-term investments
4,435
2,619
0
0
0
0
Others
65
37
121
1,201
1,596
2,221
Net cash from investing
(1,176)
(2,935)
(2,639)
(3,698)
(5,484)
(7,992)
Financing
Dividend paid
(207)
(399)
(1,083)
(2,918)
(4,456)
(6,849)
Net borrowings
(884)
1,685
(1,114)
612
578
316
Proceeds from share issues
(109)
246
205
0
0
0
Others
884
(40)
(152)
(1,317)
(1,317)
(1,317)
Net cash from financing
(316)
1,492
(2,144)
(3,623)
(5,196)
(7,850)
Net change in cash
Cash at the beginning of the year
2,809
3,234
4,988
10,944
23,502
65,437
Exchange difference
20
39
(178)
0
0
0
Others
405
1,715
6,134
12,559
41,935
47,221
Cash at the end of the year
3,234
4,988
10,944
23,502
65,437
112,658
GROWTH
2023A
2024A
2025A
2026E
2027E
2028E
YE 31 Dec
Revenue
11.2%
122.6%
60.3%
119.8%
44.5%
44.3%
Gross profit
25.1%
128.1%
99.3%
138.3%
47.8%
50.3%
Operating profit
87.9%
142.6%
124.7%
145.2%
52.1%
54.0%
Net profit
77.6%
137.9%
108.8%
159.7%
52.9%
54.0%
PROFITABILITY
2023A
2024A
2025A
2026E
2027E
2028E
YE 31 Dec
Gross profit margin
33.0%
33.8%
42.0%
45.6%
46.6%
48.5%
Operating margin
23.3%
25.4%
35.6%
39.7%
41.7%
44.6%
Return on equity (ROE)
16.6%
31.0%
44.2%
66.1%
57.7%
53.6%
GEARING/LIQUIDITY/ACTIVITIES
2023A
2024A
2025A
2026E
2027E
2028E
YE 31 Dec
Current ratio (x)
2.6
2.8
2.7
4.0
4.0
5.3
VALUATION
2023A
2024A
2025A
2026E
2027E
2028E
YE 31 Dec
P/E
284.7
120.6
58.1
22.6
14.8
9.6
P/E (diluted)
288.8
123.0
58.6
22.6
14.8
9.6
Source: Company data, CMBIGM estimates. Note: The calculation of net cash includes financial assets.


Disclosures & Disclaimers
Analyst Certification
The research analyst who is primary responsible for the content of this research report, in whole or in part, certifies that with respect to the securities or issuer that the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about the subject securities or issuer; and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific views expressed by that analyst in this report. Besides, the analyst confirms that neither the analyst nor his/her associates (as defined in the code of conduct issued by The Hong Kong Securities and Futures Commission) (1) have dealt in or traded in the stock(s) covered in this research report within 30 calendar days prior to the date of issue of this report; (2) will deal in or trade in the stock(s) covered in this research report 3 business days after the date of issue of this report; (3) serve as an officer of any of the Hong Kong listed companies covered in this report; and (4) have any financial interests in the Hong Kong listed companies covered in this report.
CMBIGM Ratings
BUY : Stock with potential return of over 15% over next 12 months
HOLD : Stock with potential return of +15% to -10% over next 12 months
SELL : Stock with potential loss of over 10% over next 12 months
NOT RATED : Stock is not rated by CMBIGM
OUTPERFORM : Industry expected to outperform the relevant broad market benchmark over next 12 months
MARKET-PERFORM : Industry expected to perform in-line with the relevant broad market benchmark over next 12 months
UNDERPERFORM Industry expected to underperform the relevant broad market benchmark over next 12 months
CMB International Global Markets Limited
Address: 45/F, Champion Tower, 3 Garden Road, Hong Kong, Tel: (852) 3900 0888 Fax: (852) 3900 0800
CMB International Global Markets Limited ("CMBIGM") is a wholly owned subsidiary of CMB International Capital Corporation Limited (a wholly owned
subsidiary of China Merchants Bank)
Important Disclosures
There are risks involved in transacting in any securities. The information contained in this report may not be suitable for the purposes of all investors. CMBIGM does not provide individually tailored investment advice. This report has been prepared without regard to the individual investment objectives, financial position or special requirements. Past performance has no indication of future performance, and actual events may differ materially from that which is contained in the report. The value of, and returns from, any investments are uncertain and are not guaranteed and may fluctuate as a result of their dependence on the performance of underlying assets or other variable market factors. CMBIGM recommends that investors should independently evaluate particular investments and strategies, and encourages investors to consult with a professional financial advisor in order to make their own investment decisions.
This report or any information contained herein, have been prepared by the CMBIGM, solely for the purpose of supplying information to the clients of CMBIGM or its affiliate(s) to whom it is distributed. This report is not and should not be construed as an offer or solicitation to buy or sell any security or any interest in securities or enter into any transaction. Neither CMBIGM nor any of its affiliates, shareholders, agents, consultants, directors, officers or employees shall be liable for any loss, damage or expense whatsoever, whether direct or consequential, incurred in relying on the information contained in this report. Anyone making use of the information contained in this report does so entirely at their own risk.
The information and contents contained in this report are based on the analyses and interpretations of information believed to be publicly available and reliable. CMBIGM has exerted every effort in its capacity to ensure, but not to guarantee, their accuracy, completeness, timeliness or correctness. CMBIGM provides the information, advices and forecasts on an "AS IS" basis. The information and contents are subject to change without notice. CMBIGM may issue other publications having information and/ or conclusions different from this report. These publications reflect different assumption, point-of-view and analytical methods when compiling. CMBIGM may make investment decisions or take proprietary positions that are inconsistent with the recommendations or views in this report.
CMBIGM may have a position, make markets or act as principal or engage in transactions in securities of companies referred to in this report for itself and/or on behalf of its clients from time to time. Investors should assume that CMBIGM does or seeks to have investment banking or other business relationships with the companies in this report. As a result, recipients should be aware that CMBIGM may have a conflict of interest that could affect the objectivity of this report and CMBIGM will not assume any responsibility in respect thereof. This report is for the use of intended recipients only and this publication, may not be reproduced, reprinted, sold, redistributed or published in whole or in part for any purpose without prior written consent of CMBIGM. Additional information on recommended securities is available upon request
Additional information on recommended securities is available upon request.
For recipients of this document in the United Kingdom
This report has been provided only to persons (I)falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended from time to time)("The Order") or (II) are persons falling within Article 49(2) (a) to (d) ("High Net Worth Companies, Unincorporated Associations, etc.,) of the Order, and may not be provided to any other person without the prior written consent of CMBIGM.
For recipients of this document in the United States
CMBIGM is not a registered broker-dealer in the United States. As a result, CMBIGM is not subject to U.S. rules regarding the preparation of research reports and the independence of research analysts. The research analyst who is primary responsible for the content of this research report is not registered or qualified as a research analyst with the Financial Industry Regulatory Authority ("FINRA"). The analyst is not subject to applicable restrictions under FINRA Rules intended to ensure that the analyst is not affected by potential conflicts of interest that could bear upon the reliability of the research report. This report is intended for distribution in the United States solely to "major US institutional investors", as defined in Rule 15a-6 under the US, Securities Exchange Act of 1934, as amended, and may not be furnished to any other person in the United States. Each major US institutional investor that receives a copy of this report by its acceptance hereof represents and agrees that it shall not distribute or provide this report to any other person. Any U.S. recipient of this report wishing to effect any transaction to buy or sell securities based on the information provided in this report should do so only through a U.S.-registered broker-dealer.
For recipients of this document in Singapore
This report is distributed in Singapore by CMBI (Singapore) Pte. Limited (CMBISG) (Company Regn. No. 201731928D), an Exempt Financial Adviser as defined in the Financial Advisers Act (Cap. 110) of Singapore and regulated by the Monetary Authority of Singapore. CMBISG may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, as defined in the Securities and Futures Act (Cap. 289) of Singapore, CMBISG accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact CMBISG at +65 6350 4400 for matters arising from, or in connection with the report.
本站所有资讯是用户利用其本地Agent获取并分享,均为公开信息,如需删除请联系我们。

